Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Anticancer Research|July 24, 2010
Vulvar cancer: prognostic factorsMaria Ornella Nicoletto, Anna Parenti, Paola Del Bianco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancerMaria Ornella Nicoletto, Roberta Bertorelle, Lucia Borgato, et al.
Oncotarget|December 30, 2016
Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cellsAnna Pastò, Anna Pagotto, Giorgia Pilotto, et al.
Oncotarget|June 21, 2014
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivationAnna Pastò, Chiara Bellio, Giorgia Pilotto, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 6, 2019
Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the DiseaseMariangela Trento, Giada Munari, Valentina Carraro, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Tumori|October 1, 2008
Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancerMaria Ornella Nicoletto, Donato Nitti, Luigi Pescarini, et al.
Anticancer Research|December 7, 2016
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral ChemotherapyMaria Ornella Nicoletto, Alessandra Casarin, Alessandra Baldoni, et al.
Tumori|March 11, 2011
Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancerMaria Ornella Nicoletto, Maurizia Dalla Palma, Martin E Donach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III studyAdriano Paccagnella, Francesco Oniga, Alessandra Bearz, et al.
Pageof 4